<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="./dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs001543.v1.p1" parentStudy="phs001543.v1.p1" createDate="2018-02-13" modDate="2020-04-20">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigator</td><td>Stefan K&#228;&#228;b, MD, PhD</td><td>Department of Medicine I, University Hospital Munich, Ludwig Maximilians University Munich, Germany</td></tr>
		<tr><td>Co-Principal Investigator</td><td>Moritz Sinner, MD, MPH</td><td>Department of Medicine I, University Hospital Munich, Ludwig Maximilians University Munich, Germany</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>NHLBI TOPMed - NHGRI CCDG: AFLMU</StudyNameEntrez>
	<StudyNameReportPage>NHLBI TOPMed - NHGRI CCDG: AF Biobank LMU in the context of the MED Biobank LMU</StudyNameReportPage>
	<StudyTypes>
		<StudyType>Case Set</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>The Atrial Fibrillation Biobank Ludwig Maximilian University (AFLMU) Study contributes to the spectrum of disease by adding carefully characterized patients with atrial fibrillation. Atrial fibrillation, one of the most common human arrhythmias confers major morbidity, mortality and health care cost, and has been demonstrated to be caused and influenced by genetic and -omics factors. Particularly, AFLMU enrolled patients with an early onset of atrial fibrillation to increase the genetic burden on disease pathophysiology. All patients were recruited applying standardized protocols to maintain homogeneity in data and DNA quality.</p>]]>
	</Description>
	<StudyInEx><![CDATA[
<p>Inclusion criteria encompassed diagnosis of atrial fibrillation with a disease onset at &#8804;65years, or presentation for catheter ablation of atrial fibrillation.</p>]]>
	</StudyInEx>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Publications>
		<Publication>
			<Pubmed pmid="28416818"/>
		</Publication>
		<Publication>
			<Pubmed pmid="27824142"/>
		</Publication>
		<Publication>
			<Pubmed pmid="25124494"/>
		</Publication>
		<Publication>
			<Pubmed pmid="24486271"/>
		</Publication>
		<Publication>
			<Pubmed pmid="22544366"/>
		</Publication>
	</Publications>
	<Diseases>
		<Disease vocab_source="MESH" vocab_term="Atrial Fibrillation"/>
	</Diseases>
	<Attributions>
		<Header title="Principal Investigator">
			<AttName>Stefan K&#228;&#228;b, MD, PhD</AttName>
			<Institution>Department of Medicine I, University Hospital Munich, Ludwig Maximilians University Munich, Germany</Institution>
		</Header>
		<Header title="Co-Principal Investigator">
			<AttName>Moritz Sinner, MD, MPH</AttName>
			<Institution>Department of Medicine I, University Hospital Munich, Ludwig Maximilians University Munich, Germany</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>yes</DisplayPublicSummary>
	<StudyHistory><![CDATA[
<p>AFLMU was initiated originally in 2001 (then MAGiC-AF Project) and has consecutively been continuing patient enrollment since.</p>]]>
	</StudyHistory>
	<ConsentGroups>
		<ConsentGroup groupNum="1" shortName="HMB-IRB-PUB-COL-NPU-MDS" longName="Health/Medical/Biomedical (IRB, PUB, COL, NPU, MDS)"/>
	</ConsentGroups>
</Configuration>

  <AuthorizedAccess>
    <DacInfo ssDacId="0">
      <DacName>NHLBI</DacName>
      <DacFullName>National Heart, Lung, and Blood Institute DAC</DacFullName>
      <DacEmail>0</DacEmail>
      <DacPhone/>
      <DacUrl/>
    </DacInfo>
    <Policy Policy_ID="phs001543.v1.p1_policy" ref_ssDacId="0">
      <DisplayResearchStatement>yes</DisplayResearchStatement>
      <DisplayPublicSummary>yes</DisplayPublicSummary>
      <EmbargoLength>0</EmbargoLength>
      <YearsUntilRenewal>1</YearsUntilRenewal>
      <WeeksCancelRequest>8</WeeksCancelRequest>
      <PdfSupplementReqired>yes</PdfSupplementReqired>
      <AcknowledgementText>
        <para>
          http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs001543.v1.p1
        </para>
      </AcknowledgementText>
      <DocumentSet>
        <DataUseCertificate Label="Data Use Certificate" FilePath="https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs001543.v1.p1" FileName=""/>
      </DocumentSet>
    </Policy>
    <ConsentGroups>
      <ParticipantSet groupNum-REF="1">
        <ConsentName>Health/Medical/Biomedical (IRB, PUB, COL, NPU, MDS)</ConsentName>
        <ConsentAbbrev>HMB-IRB-PUB-COL-NPU-MDS</ConsentAbbrev>
        <UseLimitation>Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.
Requestor must provide documentation of local IRB approval.
Requestor agrees to make results of studies using the data available to the larger scientific community.
Requestor must provide a letter of collaboration with the primary study investigator(s).
Use of the data is limited to not-for-profit organizations.
Use of the data includes methods development research (e.g., development of software or algorithms).</UseLimitation>
        <IrbRequired>Yes</IrbRequired>
      </ParticipantSet>
    </ConsentGroups>
  </AuthorizedAccess>
  <Documents>
    <Document phd="phd008024.1" type="protocol" createDate="2019-09-25" modDate="2020-03-17" urlToXml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/GetDocumentXml.cgi?document_id=phd008024.1" urlToHtml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/document.cgi?study_id=phs001543.v1.p1&amp;phd=8024">
      <OrigName>TOPMed_WGS_Methods_Freeze8.docx</OrigName>
      <DisplayName>TOPMed Whole Genome Sequencing Methods: Freeze 8</DisplayName>
      <Description>TOPMed Whole Genome Sequencing Methods: Freeze 8</Description>
      <displayStatus>public</displayStatus>
      <xmlStatus>public</xmlStatus>
    </Document>
  </Documents>



</Study>

</Studies>

</GaPExchange>
